Brain, new growth of, malignant
The VA rates Brain, new growth of, malignant under Diagnostic Code 8002 across 2 severity levels, from 30% to 100%. The applicable level depends on the full criteria and the evidence for the condition. These percentages are alternatives, not amounts to add together.
Rating schedule — DC 8002 at a glance
- Minimum rating
- 30%
- Maximum rating
- 100%
- Rating tiers
- 2
- CFR section
- § 4.124a
- Body system
- Neurological Conditions
- Secondary conditions
- 0
Lowest schedular rating available
Full schedular disability
30%, 100%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Brain, new growth of, malignant?
| Rating | Criteria |
|---|---|
| 30% | Minimum rating |
| 100% | Malignant |
“Malignant”
What other neurological conditions does the VA rate?
These diagnostic codes sit next to Brain, new growth of, malignant in 38 CFR Part 4. The rating schedule is ordered anatomically, so neighbouring codes usually cover the same joint, organ, or system, and a claim often involves more than one of them.
- 8000Encephalitis, epidemic, chronicRated up to 100%
- 8003Brain, new growth of, benignRated up to 60%
- 8004Paralysis agitansRated up to 30%
- 8005Bulbar palsyRated up to 100%
- 8009Brain, vessels, hemorrhage fromRated up to 100%
- 8010MyelitisRated up to 10%
- 8011Poliomyelitis, anteriorRated up to 100%
- 8012HematomyeliaRated up to 100%
- 8017Amyotrophic lateral sclerosisRated up to 100%
- 8018Multiple sclerosisRated up to 30%
Common Questions About Brain, new growth of, malignant VA Ratings
What is the VA rating range for Brain, new growth of, malignant?
The VA rates Brain, new growth of, malignant under Diagnostic Code 8002 at 30%, 100%. The minimum 30% rating requires: Minimum rating. The maximum 100% rating requires: Malignant.
Which 38 CFR diagnostic code does the VA use for Brain, new growth of, malignant?
The VA rates Brain, new growth of, malignant under Diagnostic Code (DC) 8002, governed by 38 CFR 38 CFR § 4.124a. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
What is the difference between a 30% and a 100% rating for Brain, new growth of, malignant?
A 30% rating requires: Minimum rating. A 100% rating requires: Malignant. The difference typically reflects the frequency, severity, or functional impact of the condition as documented in medical records and C&P examination findings.
Can Brain, new growth of, malignant qualify for TDIU?
Yes — a 100% rating for Brain, new growth of, malignant alone meets the single-disability threshold for TDIU (38 CFR § 4.16). If the condition prevents substantially gainful employment, the veteran is compensated at the 100% rate without a schedular 100% rating.
What evidence supports a higher rating for Brain, new growth of, malignant?
The key evidence for Brain, new growth of, malignant is documentation of how the condition affects daily functioning. For neurological conditions, nerve conduction studies, EMG results, and documentation of complete vs incomplete paralysis distinguish the rating tiers. A nexus letter from a qualified medical professional linking the current severity to service is essential for contested claims.
What happens at the C&P exam for Brain, new growth of, malignant?
The C&P examiner uses a Neurological Conditions DBQ and evaluates your condition against the DC 8002 rating criteria. The examiner tests reflexes, sensation, and motor function. If nerve damage is suspected, EMG or nerve conduction studies may be ordered. Distinguish between complete and incomplete paralysis — the rating difference is significant.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits